Why the gradual increase
Multiple variants of GLP-1 drugs have recently been introduced in the Indian market, and concerns have emerged about their on-demand availability through retail pharmacies, online platforms, wholesalers, and wellness clinics
LDL, low-density lipoprotein
Tirzepatide Next-generation dual-receptor therapy Activates both GLP-1 and GIP receptors delivering superior appetite control and stronger metabolic outcomes than single-pathway medications
Zoe Quandt Our findings build on prior reports of lower cancer rates in patients on GLP-1s, showing that patients that are prescribed GLP-1s have better survival than those without these agents, particularly in comparison to the addition of insulin, Zoe Quandt, MD, MS, assistant professor in the division of diabetes, endocrinology and metabolism at the Diabetes Center at University of California, San Francisco, told Healio